See more : Fintech Select Ltd. (FTEC.V) Income Statement Analysis – Financial Results
Complete financial analysis of Reliq Health Technologies Inc. (RQHTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reliq Health Technologies Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- SentinelOne, Inc. (S) Income Statement Analysis – Financial Results
- ZONBONG LANDSCAPE Environmental Limited (1855.HK) Income Statement Analysis – Financial Results
- Hing Lee (HK) Holdings Limited (0396.HK) Income Statement Analysis – Financial Results
- Infraset Public Company Limited (INSET.BK) Income Statement Analysis – Financial Results
- Ador Welding Limited (ADORWELD.BO) Income Statement Analysis – Financial Results
Reliq Health Technologies Inc. (RQHTF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.reliqhealth.com
About Reliq Health Technologies Inc.
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.55M | 1.46M | 1.14M | 181.91K | 2.27M | 182.65K | 536.20K | 31.62K | 29.74K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
| Cost of Revenue | 3.25M | 7.26M | 7.52M | 5.84M | 12.24M | 960.12K | 544.48K | 1.85K | 93.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 5.30M | -5.80M | -6.38M | -5.66M | -9.97M | -777.47K | -8.28K | 29.77K | -63.58K | 61.91K | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 274.00 |
| Gross Profit Ratio | 61.99% | -396.52% | -558.27% | -3,112.71% | -439.17% | -425.65% | -1.54% | 94.15% | -213.83% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% |
| Research & Development | 2.22M | 1.73M | 1.72M | 5.15M | 1.42M | 719.41K | 447.23K | 270.20K | 432.89K | 510.83K | 172.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 10.03M | 10.11M | 8.82M | 7.33M | 12.00M | 1.80M | 1.84M | 4.06M | 331.33K | 517.42K | 398.62K | 812.67K | 769.08K | 663.98K | 44.57K | 0.00 | 0.00 |
| Selling & Marketing | 492.65K | 515.70K | 353.48K | 274.48K | 381.68K | 311.50K | 354.60K | 211.65K | 11.24K | 10.30K | 11.67K | 42.26K | 177.38K | 31.29K | 412.00 | 0.00 | 0.00 |
| SG&A | 10.52M | 4.10M | 3.06M | 2.64M | 2.40M | 1.30M | 1.97M | 4.27M | 331.33K | 517.42K | 410.29K | 854.94K | 946.46K | 695.27K | 44.98K | 109.46K | 1.00K |
| Other Expenses | 888.82K | -5.64K | -58.35K | -34.40K | -32.97K | 189.88K | 18.25K | 0.00 | 0.00 | 0.00 | -2.02K | -3.61K | -28.09K | 1.67K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 13.63M | 5.83M | 4.84M | 7.82M | 3.82M | 2.02M | 2.42M | 4.54M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
| Cost & Expenses | 16.88M | 13.09M | 12.37M | 13.67M | 16.06M | 2.98M | 2.96M | 4.55M | 333.51K | 518.90K | 527.03K | 856.88K | 947.10K | 695.27K | 44.98K | 109.46K | 1.00K |
| Interest Income | 76.61K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 43.81K | 11.00 | 2.24K | 5.74K | 1.73K | 12.31K | 13.99K | 12.69K | 274.00 |
| Interest Expense | 35.28K | 46.62K | 36.19K | 0.00 | 25.00 | 14.48K | 0.00 | 41.28K | 0.00 | 1.17K | 813.00 | 1.11K | 698.00 | 631.00 | 123.00 | 113.00 | 0.00 |
| Depreciation & Amortization | 115.29K | 125.76K | 445.41K | 634.16K | 634.16K | 2.05K | 6.17K | 6.17K | 2.18K | 1.49K | 938.00 | 1.94K | 639.00 | 11.28K | 123.00 | 0.00 | 0.00 |
| EBITDA | -8.02M | -11.51M | -10.78M | -12.85M | -12.65M | -2.80M | -2.42M | -2.40M | -928.85K | 367.16K | 223.33K | -854.94K | -972.83K | -684.63K | -44.98K | -109.46K | -726.00 |
| EBITDA Ratio | -93.79% | -786.98% | -943.01% | -7,064.61% | -607.62% | -1,532.76% | -451.51% | -14,261.37% | 311.96% | 593.03% | 14,918.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
| Operating Income | -8.30M | -11.63M | -11.22M | -13.49M | -13.79M | -2.80M | -2.43M | -2.45M | -317.35K | -518.90K | -526.04K | -857.99K | -947.80K | -695.90K | -45.10K | -109.46K | -726.00 |
| Operating Income Ratio | -97.01% | -795.58% | -981.98% | -7,413.23% | -607.62% | -1,533.88% | -452.66% | -7,764.22% | -1,067.26% | -838.13% | -35,139.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
| Total Other Income/Expenses | 124.77K | -101.19K | 33.51K | 301.31K | -163.28K | 340.54K | -412.46K | -2.10M | -440.25K | -512.27K | -748.97K | 2.13K | -413.04K | -39.36K | 0.00 | 0.00 | 726.00 |
| Income Before Tax | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.36M | -735.26K | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 4.00 | 239.11K | 2.00 | -2.05K | 3.00 | 1.00 | -2.02M | 424.09K | 884.57K | 747.99K | -79.38K | -138.88K | -8.98K | -13.99K | 96.88K | 726.00 |
| Net Income | -8.17M | -11.78M | -11.12M | -13.00M | -13.80M | -2.46M | -2.84M | -4.56M | -757.60K | -1.40M | -1.28M | -855.86K | -1.22M | -735.26K | -31.11K | -96.88K | -726.00 |
| Net Income Ratio | -95.55% | -805.69% | -973.06% | -7,148.79% | -607.92% | -1,347.44% | -529.58% | -14,411.42% | -2,547.84% | -2,266.89% | -85,171.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -264.96% |
| EPS | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
| EPS Diluted | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | -0.04 | -0.06 | -0.25 | -0.50 | -1.18 | -1.08 | -0.84 | -1.80 | -2.81 | -0.39 | -1.39 | -0.03 |
| Weighted Avg Shares Out | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
| Weighted Avg Shares Out (Dil) | 183.09M | 157.89M | 135.22M | 118.41M | 95.40M | 59.89M | 50.16M | 18.40M | 1.52M | 1.19M | 1.18M | 1.02M | 677.49K | 261.26K | 80.00K | 69.67K | 28.44K |
Reliq Health Technologies, Inc. to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on Wednesday, January 25, 2023
HAMILTON, Ontario, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market,...
Reliq Health Technologies, Inc. to Participate in the Lytham Partners Fall 2022 Investor Conference
HAMILTON, Ontario, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market,...
Reliq Health Technologies, Inc. to Participate in the Lytham Partners Summer 2022 Investor Conference
HAMILTON, Ontario, June 16, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market,...
Reliq Health Technologies Inc. (RQHTF) CEO Lisa Crossley on Q3 2022 Results - Earnings Call Transcript
Reliq Health Technologies Inc. (OTCPK:RQHTF) Q3 2022 Earnings Conference Call May 31, 2022 9:00 AM ET Company Participants Dr. Lisa Crossley - CEO Conference Call Participants Dr. Lisa Crossley Good morning and thank you for joining us. Today is May...
Reliq Health Technologies, Inc. to Present at the Lytham Partners Spring 2022 Investor Conference
HAMILTON, Ontario, March 31, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market,...
Reliq Health Technologies Has Reached An Inflection Point
The company still saw 36% sequential growth despite Omicron headwind. CAD$2M run rate in December reflects CAD $24M annually; they are still on course to meet CAD$40M 2022 reaffirmed guidance.
Reliq Health Technologies Inc. (RQHTF) CEO Lisa Crossley on Q2 2022 Results - Earnings Call Transcript
Reliq Health Technologies Inc. (RQHTF) CEO Lisa Crossley on Q2 2022 Results - Earnings Call Transcript
Reliq Health Technologies, Inc. to Present at Gravitas' 5th Annual Growth Conference
HAMILTON, Ontario, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is...
Reliq Health Technologies Inc. (RQHTF) CEO Lisa Crossley on Q1 Fiscal Year 2022 Results - Earning Calls Transcript
Reliq Health Technologies Inc. (RQHTF) CEO Lisa Crossley on Q1 Fiscal Year 2022 Results - Earning Calls Transcript
Reliq Health Technologies, Inc. to Present at GCFF Virtual Conference Main Event - Small Cap Investing
HAMILTON, Ontario, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF) (“Reliq” or the “Company”), a rapidly growing global telemedicine that specializes in developing innovative Virtual Care solutions for the multi-billion dollar medtech market, today announced...
Source: https://incomestatements.info
Category: Stock Reports